PPARA and hypertriglyceridemia: Fenofibrate has been used clinically for decades to manage hypertriglyceridemia, and its action is mediated by the peroxisome proliferator-activated receptor alpha (PPARα), a nuclear receptor that regulates the genes for fatty acid catabolism.